BioSpace News Archive

Business

BioSpace Movers & Shakers, April 15: Spruce, Nautilus, Alto, Ikena Oncology

Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

April 14, 2022
·
8 min read
·
Alex Keown
Drug Development

Highlights from AACR’s Final Day: Mustang Bio, ChemoCentryx, Allogene and More

The AACR annual meeting concluded on April 13, showcasing hundreds of preclinical to late-stage information from ongoing studies on treatment candidates.

April 14, 2022
·
4 min read
·
Vanessa Doctor, RN
Roche Wakes Up to New Competition as FDA Approves Amneal’s Avastin Biosimilar

Amneal Pharmaceuticals received the green light from the U.S. Food and Drug Administration for bevacizumab-maly, a biosimilar to Genentech (Roche)’s Avastin.

April 14, 2022
·
2 min read
·
Alex Keown
Drug Development

Pfizer, BioNTech Seek Approval for Boosters in Children Following Positive Data

Pfizer and BioNTech will submit updated data to the FDA to support the Emergency Use Authorization (EUA) of COVID-19 vaccination boosters in children between the age of 5 and 11.

April 14, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Drug Development

Merck’s Pneumococcal Vaccine Claims FDA Breakthrough Therapy Designation

The FDA granted Merck’s investigational 21-valent pneumococcal conjugate vaccine (V116) for IPD and pneumococcal pneumonia Breakthrough Therapy Designation.

April 14, 2022
·
3 min read
·
Mark Terry
FDA

FDA Issues New Guidance to Increase Minority Representation in Clinical Trials

The FDA issued new guidance urging drugmakers to submit racial and minority recruitment plans when designing their studies.

April 14, 2022
·
3 min read
·
Alex Keown
Spinal Traction Market: Increasing Use of spinal traction in the Healthcare Sector Present Lucrative Opportunities for the Key players

The report offers key drivers that propel the growth in the global Spinal Traction Market.

April 14, 2022
·
3 min read
Biotech Beach

Eledon to Host Virtual R&D Day on Thursday, April 28, 2022

Eledon Pharmaceuticals, Inc. announced that it will host its first R&D Day on Thursday, April 28, 2022, from 10 a.m. to 12 p.m. ET.

April 14, 2022
·
2 min read
Business

Sight Sciences to Report First Quarter 2022 Financial Results on May 10, 2022

Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced it will report financial results for the quarter ended March 31, 2022, after the market close on Tuesday, May 10, 2022.

April 14, 2022
·
1 min read
Business

Azenta Life Sciences Announces Fiscal 2022 Second Quarter Earnings Conference Call and Webcast

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal 2022 second quarter earnings which ended on March 31, 2022 on Tuesday, May 3, 2022 after the market closes.

April 14, 2022
·
1 min read